Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Copenhagen | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of this study is to assess the induction of neuroinflammation in brain regions of interest for learning and memory in adult patients undergoing urological surgery under general anesthesia
The investigators aim to study immune cell activation as a biomarker for neuroinflammation using the cell specific [11C]PBR28 probe as detected by PET imaging techniques.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Positron emission tomography (PET) | Experimental | Positron emission tomography (PET) using [11C]PBR28 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Positron emission tomography (PET) using [11C]PBR28 | Radiation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Binding of the PET probe [11C]PBR28 | PET imaging of brain regions of relevance for memory and learning will be compared between the pre- and postoperative states. | Preoperatively, once at postoperative day 2-5 and after 3 month |
| Measure | Description | Time Frame |
|---|---|---|
| Cognitive testing | Postoperative cognitive test battery according to the ISPOCD protocol, see Moller JT et al, Lancet 1998. | Preoperatively and after 3 month |
| Inflammatory biomarkers | Inflammatory biomarkers and genetic analysis of inflammatory biomarkers in blood. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lars I Eriksson, MD,PhD, Professor | Karolinska University Hospital and Karolinska Institutet | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D020078 | Neurogenic Inflammation |
| D060825 | Cognitive Dysfunction |
| D000090862 | Neuroinflammatory Diseases |
| D000079690 | Postoperative Cognitive Complications |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D009682 | Magnetic Resonance Spectroscopy |
| C062942 | 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole |
| C526315 | (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine |
| ID | Term |
|---|---|
| D013057 | Spectrum Analysis |
| D002623 | Chemistry Techniques, Analytical |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Preoperatively, once at postoperative day 2-5 and after 3 month, i.e. at the same time as the PET investigation |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D011183 | Postoperative Complications |